The percentages of PD1+, CD8+, and PD1+CD8+ T cells, as well as the PD1+CD8+/CD8+ ratio, in the whole tumor, stromal, and intratumoral area were analyzed (Fig 2a–d). This evidence concerns the gene CD8A and neoplasm.